Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Learn what customers are saying about no annual fee travel credit cards. Gain insights to help you choose the right card for your travels.
22,936 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
A couple with about $2M saved, no debt, and a paid-off home faces a looming retirement tax bill, according to Suze Or...
As Apple eyes a leadership transition, analysts debate whether Apple stock will outpace the S&P 500 in the new CEO’s ...
A veteran analyst warns that today may be one of the most dangerous eras for passive investing. With stocks near all-...
A single, fixable flaw undermines most households' budgets: the failure to automate saving and bill payments. Here's ...
In 2025, Marathon Petroleum delivered a powerful cash-return story for shareholders. This article breaks down how the...
A crypto exchange’s bold political donations can reshape its regulatory path and banking access. This genre of analys...
Household bills are climbing again amid a web of factors from aging infrastructure to data-center demand. This report...
When markets wobble, a steady plan can turn volatility into opportunity. Learn how one Vanguard ETF helps you practic...
As AI stocks cool, a rotation toward durable, revenue-generating assets accelerates. A new wheel technology startup i...
January new-home activity sank 17.6% to 587,000 SAAR, with prices sliding and winter weather cited as a key acceleran...
The U.S. debt held by the public has eclipsed nominal GDP for the first time since World War II, a milestone that cou...